TipRanks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
ELTP
Elite Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELTP full AI Analyst Report?

Elite Pharmaceuticals (ELTP) Income Statement

379 Followers

Elite Pharmaceuticals Income Statement

Last quarter (Q1 2027), Elite Pharmaceuticals's total revenue was $32.36M, an increase of 1.12% from the same quarter last year. In Q1, Elite Pharmaceuticals's net income was $5.91M. See Elite Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Jun 25Jun 24Mar 23Mar 22
Total Revenue
$ 148.87M$ 84.04M$ 56.63M$ 34.16M$ 32.26M
Gross Profit
$ 73.48M$ 40.09M$ 26.36M$ 16.59M$ 14.80M
Operating Expenses
$ 23.52M$ 20.49M$ 15.57M$ 12.92M$ 9.72M
Depreciation and Amortization
$ 2.02M$ 2.12M$ 1.47M$ 1.34M$ 1.43M
EBITDA
$ 51.98M$ 2.84M$ 2.52M$ 6.44M$ 6.51M
Operating Income
$ 49.96M$ 19.60M$ 10.79M$ 2.03B$ 5.07M
Other Income/Expenses
$ 6.85M$ -19.65M$ -10.33M$ 309.87K$ 2.09M
Pretax Income
$ 56.81M$ -52.14K$ 463.09K$ 3.99M$ 7.16M
Net Income
$ 44.87M$ -4.31M$ 20.11M$ 4.41M$ 8.90M
Per Share Metrics
Basic EPS
$ 0.04$ 0.00$ 0.02$ 4.35$ <0.01
Diluted EPS
$ 0.03$ 0.00$ 0.02$ 4.35$ <0.01
Weighted Average Shares Outstanding
 1.07B 1.07B 1.02B 1.01B 1.01B
Weighted Average Shares Outstanding (Diluted)
 1.14B 1.07B 1.02B 1.01B 1.01B
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History